Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.8301
-0.0077 (-0.92%)
At close: Jul 11, 2025, 4:00 PM
0.8361
+0.0060 (0.72%)
After-hours: Jul 11, 2025, 7:27 PM EDT
Immunic Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,059,297
Market Cap
79.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMUX News
- 17 days ago - Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis - PRNewsWire
- 4 weeks ago - Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted - Seeking Alpha
- 5 weeks ago - Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - PRNewsWire
- 5 weeks ago - Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - PRNewsWire
- 5 weeks ago - Immunic to Participate in Investor, Scientific and Industry Conferences in June - PRNewsWire
- 6 weeks ago - Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - PRNewsWire
- 6 weeks ago - Immunic, Inc. Announces Proposed Public Offering - PRNewsWire
- 2 months ago - Immunic to Participate in Scientific and Industry Conferences in May - PRNewsWire